APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Leukocyte Surface Antigen CD47

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Leukocyte Surface Antigen CD47 Industry Growth and Trends Forecast to 2032

22 December 202591 pages

Choose your research edition.

Industry ResearchLeukocyte Surface Antigen CD47 Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Leukocyte Surface Antigen CD47 Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Leukocyte Surface Antigen CD47 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Leukocyte Surface Antigen CD47 Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Leukocyte Surface Antigen CD47 Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Leukocyte Surface Antigen CD47 market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Leukocyte Surface Antigen CD47 is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Leukocyte Surface Antigen CD47 is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Leukocyte Surface Antigen CD47 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Leukocyte Surface Antigen CD47 include Trillium Therapeutics Inc, Surface Oncology Inc, Forty Seven Inc, Celgene Corp and Aurigene Discovery Technologies Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Leukocyte Surface Antigen CD47 market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Leukocyte Surface Antigen CD47 market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Leukocyte Surface Antigen CD47 market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Leukocyte Surface Antigen CD47.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Leukocyte Surface Antigen CD47 market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Leukocyte Surface Antigen CD47 Market by Company

Trillium Therapeutics Inc

Surface Oncology Inc

Forty Seven Inc

Celgene Corp

Aurigene Discovery Technologies Ltd

Leukocyte Surface Antigen CD47 Segment by Type

PSTx-23

CC-90002

B-6H12

ALX-148

Others

Leukocyte Surface Antigen CD47 Segment by Application

Ischemia Reperfusion Injury

Kindney Transplant Rejection

Ovarian Cancer

Lymphoma

Others

Leukocyte Surface Antigen CD47 Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Leukocyte Surface Antigen CD47 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Leukocyte Surface Antigen CD47 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Leukocyte Surface Antigen CD47.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Leukocyte Surface Antigen CD47 manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Leukocyte Surface Antigen CD47 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of PSTx-23 Table 2. Major Company of CC-90002 Table 3. Major Company of B-6H12 Table 4. Major Company of ALX-148 Table 5. Major Company of Others Table 6. Global Leukocyte Surface Antigen CD47 Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Leukocyte Surface Antigen CD47 Sales by Type (2021-2026) & (k units) Table 8. Global Leukocyte Surface Antigen CD47 Sales Market Share in Volume by Type (2021-2026) Table 9. Global Leukocyte Surface Antigen CD47 Sales by Type (2021-2026) & (US$ Million) Table 10. Global Leukocyte Surface Antigen CD47 Sales Market Share in Value by Type (2021-2026) Table 11. Global Leukocyte Surface Antigen CD47 Price by Type (2021-2026) & (US$/unit) Table 12. Global Leukocyte Surface Antigen CD47 Sales by Type (2027-2032) & (k units) Table 13. Global Leukocyte Surface Antigen CD47 Sales Market Share in Volume by Type (2027-2032) Table 14. Global Leukocyte Surface Antigen CD47 Sales by Type (2027-2032) & (US$ Million) Table 15. Global Leukocyte Surface Antigen CD47 Sales Market Share in Value by Type (2027-2032) Table 16. Global Leukocyte Surface Antigen CD47 Price by Type (2027-2032) & (US$/unit) Table 17. North America Leukocyte Surface Antigen CD47 Sales by Type (2021-2026) & (k units) Table 18. North America Leukocyte Surface Antigen CD47 Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Leukocyte Surface Antigen CD47 Sales by Type (2021-2026) & (k units) Table 20. Europe Leukocyte Surface Antigen CD47 Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Leukocyte Surface Antigen CD47 Sales by Type (2021-2026) & (k units) Table 22. Asia-Pacific Leukocyte Surface Antigen CD47 Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Leukocyte Surface Antigen CD47 Sales by Type (2021-2026) & (k units) Table 24. Latin America Leukocyte Surface Antigen CD47 Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Leukocyte Surface Antigen CD47 Sales by Type (2021-2026) & (k units) Table 26. Middle East and Africa Leukocyte Surface Antigen CD47 Sales by Type (2021-2026) & (US$ Million) Table 27. Leukocyte Surface Antigen CD47 Industry Trends Table 28. Leukocyte Surface Antigen CD47 Industry Drivers Table 29. Leukocyte Surface Antigen CD47 Industry Opportunities and Challenges Table 30. Leukocyte Surface Antigen CD47 Industry Restraints Table 31. Global Leukocyte Surface Antigen CD47 Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Leukocyte Surface Antigen CD47 Revenue Market Share by Company (2021-2026) Table 33. Global Leukocyte Surface Antigen CD47 Sales by Company (2021-2026) & (k units) Table 34. Global Leukocyte Surface Antigen CD47 Sales Share by Company (2021-2026) Table 35. Global Leukocyte Surface Antigen CD47 Market Price by Company (2021-2026) & (US$/unit) Table 36. Global Leukocyte Surface Antigen CD47 Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Leukocyte Surface Antigen CD47 Major Company Production Sites and Headquarters Table 38. Global Leukocyte Surface Antigen CD47 Company, Product Type & Application Table 39. Global Leukocyte Surface Antigen CD47 Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Leukocyte Surface Antigen CD47 by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Leukocyte Surface Antigen CD47 Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Leukocyte Surface Antigen CD47 Sales by Region (2021-2026) & (k units) Table 44. Global Leukocyte Surface Antigen CD47 Sales Market Share in Volume by Region (2021-2026) Table 45. Global Leukocyte Surface Antigen CD47 Sales by Region (2021-2026) & (US$ Million) Table 46. Global Leukocyte Surface Antigen CD47 Sales Market Share in Value by Region (2021-2026) Table 47. Global Leukocyte Surface Antigen CD47 Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 48. Global Leukocyte Surface Antigen CD47 Sales by Region (2027-2032) & (k units) Table 49. Global Leukocyte Surface Antigen CD47 Sales Market Share in Volume by Region (2027-2032) Table 50. Global Leukocyte Surface Antigen CD47 Sales by Region (2027-2032) & (US$ Million) Table 51. Global Leukocyte Surface Antigen CD47 Sales Market Share in Value by Region (2027-2032) Table 52. Global Leukocyte Surface Antigen CD47 Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 53. Global Leukocyte Surface Antigen CD47 Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Leukocyte Surface Antigen CD47 Sales by Application (2021-2026) & (k units) Table 55. Global Leukocyte Surface Antigen CD47 Sales Market Share in Volume by Application (2021-2026) Table 56. Global Leukocyte Surface Antigen CD47 Sales by Application (2021-2026) & (US$ Million) Table 57. Global Leukocyte Surface Antigen CD47 Sales Market Share in Value by Application (2021-2026) Table 58. Global Leukocyte Surface Antigen CD47 Price by Application (2021-2026) & (US$/unit) Table 59. Global Leukocyte Surface Antigen CD47 Sales by Application (2027-2032) & (k units) Table 60. Global Leukocyte Surface Antigen CD47 Sales Market Share in Volume by Application (2027-2032) Table 61. Global Leukocyte Surface Antigen CD47 Sales by Application (2027-2032) & (US$ Million) Table 62. Global Leukocyte Surface Antigen CD47 Sales Market Share in Value by Application (2027-2032) Table 63. Global Leukocyte Surface Antigen CD47 Price by Application (2027-2032) & (US$/unit) Table 64. North America Leukocyte Surface Antigen CD47 Sales by Application (2021-2026) & (k units) Table 65. North America Leukocyte Surface Antigen CD47 Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Leukocyte Surface Antigen CD47 Sales by Application (2021-2026) & (k units) Table 67. Europe Leukocyte Surface Antigen CD47 Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Leukocyte Surface Antigen CD47 Sales by Application (2021-2026) & (k units) Table 69. Asia-Pacific Leukocyte Surface Antigen CD47 Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Leukocyte Surface Antigen CD47 Sales by Application (2021-2026) & (k units) Table 71. Latin America Leukocyte Surface Antigen CD47 Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Leukocyte Surface Antigen CD47 Sales by Application (2021-2026) & (k units) Table 73. Middle East and Africa Leukocyte Surface Antigen CD47 Sales by Application (2021-2026) & (US$ Million) Table 74. Trillium Therapeutics Inc Company Information Table 75. Trillium Therapeutics Inc Business Overview Table 76. Trillium Therapeutics Inc Leukocyte Surface Antigen CD47 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 77. Trillium Therapeutics Inc Leukocyte Surface Antigen CD47 Product Portfolio Table 78. Trillium Therapeutics Inc Recent Development Table 79. Surface Oncology Inc Company Information Table 80. Surface Oncology Inc Business Overview Table 81. Surface Oncology Inc Leukocyte Surface Antigen CD47 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 82. Surface Oncology Inc Leukocyte Surface Antigen CD47 Product Portfolio Table 83. Surface Oncology Inc Recent Development Table 84. Forty Seven Inc Company Information Table 85. Forty Seven Inc Business Overview Table 86. Forty Seven Inc Leukocyte Surface Antigen CD47 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 87. Forty Seven Inc Leukocyte Surface Antigen CD47 Product Portfolio Table 88. Forty Seven Inc Recent Development Table 89. Celgene Corp Company Information Table 90. Celgene Corp Business Overview Table 91. Celgene Corp Leukocyte Surface Antigen CD47 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 92. Celgene Corp Leukocyte Surface Antigen CD47 Product Portfolio Table 93. Celgene Corp Recent Development Table 94. Aurigene Discovery Technologies Ltd Company Information Table 95. Aurigene Discovery Technologies Ltd Business Overview Table 96. Aurigene Discovery Technologies Ltd Leukocyte Surface Antigen CD47 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 97. Aurigene Discovery Technologies Ltd Leukocyte Surface Antigen CD47 Product Portfolio Table 98. Aurigene Discovery Technologies Ltd Recent Development Table 99. North America Leukocyte Surface Antigen CD47 Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 100. North America Leukocyte Surface Antigen CD47 Sales by Country (2021-2026) & (k units) Table 101. North America Leukocyte Surface Antigen CD47 Sales Market Share by Country (2021-2026) Table 102. North America Leukocyte Surface Antigen CD47 Sales Forecast by Country (2027-2032) & (k units) Table 103. North America Leukocyte Surface Antigen CD47 Sales Market Share Forecast by Country (2027-2032) Table 104. North America Leukocyte Surface Antigen CD47 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 105. North America Leukocyte Surface Antigen CD47 Market Size by Country (2021-2026) & (US$ Million) Table 106. North America Leukocyte Surface Antigen CD47 Market Share by Country (2021-2026) Table 107. North America Leukocyte Surface Antigen CD47 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 108. North America Leukocyte Surface Antigen CD47 Market Share Forecast by Country (2027-2032) Table 109. Europe Leukocyte Surface Antigen CD47 Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 110. Europe Leukocyte Surface Antigen CD47 Sales by Country (2021-2026) & (k units) Table 111. Europe Leukocyte Surface Antigen CD47 Sales Market Share by Country (2021-2026) Table 112. Europe Leukocyte Surface Antigen CD47 Sales Forecast by Country (2027-2032) & (k units) Table 113. Europe Leukocyte Surface Antigen CD47 Sales Market Share Forecast by Country (2027-2032) Table 114. Europe Leukocyte Surface Antigen CD47 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 115. Europe Leukocyte Surface Antigen CD47 Market Size by Country (2021-2026) & (US$ Million) Table 116. Europe Leukocyte Surface Antigen CD47 Market Share by Country (2021-2026) Table 117. Europe Leukocyte Surface Antigen CD47 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 118. Europe Leukocyte Surface Antigen CD47 Market Share Forecast by Country (2027-2032) Table 119. Asia-Pacific Leukocyte Surface Antigen CD47 Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 120. Asia-Pacific Leukocyte Surface Antigen CD47 Sales by Country (2021-2026) & (k units) Table 121. Asia-Pacific Leukocyte Surface Antigen CD47 Sales Market Share by Country (2021-2026) Table 122. Asia-Pacific Leukocyte Surface Antigen CD47 Sales Forecast by Country (2027-2032) & (k units) Table 123. Asia-Pacific Leukocyte Surface Antigen CD47 Sales Market Share Forecast by Country (2027-2032) Table 124. Asia-Pacific Leukocyte Surface Antigen CD47 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 125. Asia-Pacific Leukocyte Surface Antigen CD47 Market Size by Country (2021-2026) & (US$ Million) Table 126. Asia-Pacific Leukocyte Surface Antigen CD47 Market Share by Country (2021-2026) Table 127. Asia-Pacific Leukocyte Surface Antigen CD47 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 128. Asia-Pacific Leukocyte Surface Antigen CD47 Market Share Forecast by Country (2027-2032) Table 129. Latin America Leukocyte Surface Antigen CD47 Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 130. Latin America Leukocyte Surface Antigen CD47 Sales by Country (2021-2026) & (k units) Table 131. Latin America Leukocyte Surface Antigen CD47 Sales Market Share by Country (2021-2026) Table 132. Latin America Leukocyte Surface Antigen CD47 Sales Forecast by Country (2027-2032) & (k units) Table 133. Latin America Leukocyte Surface Antigen CD47 Sales Market Share Forecast by Country (2027-2032) Table 134. Latin America Leukocyte Surface Antigen CD47 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 135. Latin America Leukocyte Surface Antigen CD47 Market Size by Country (2021-2026) & (US$ Million) Table 136. Latin America Leukocyte Surface Antigen CD47 Market Share by Country (2021-2026) Table 137. Latin America Leukocyte Surface Antigen CD47 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 138. Latin America Leukocyte Surface Antigen CD47 Market Share Forecast by Country (2027-2032) Table 139. Middle East and Africa Leukocyte Surface Antigen CD47 Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 140. Middle East and Africa Leukocyte Surface Antigen CD47 Sales by Country (2021-2026) & (k units) Table 141. Middle East and Africa Leukocyte Surface Antigen CD47 Sales Market Share by Country (2021-2026) Table 142. Middle East and Africa Leukocyte Surface Antigen CD47 Sales Forecast by Country (2027-2032) & (k units) Table 143. Middle East and Africa Leukocyte Surface Antigen CD47 Sales Market Share Forecast by Country (2027-2032) Table 144. Middle East and Africa Leukocyte Surface Antigen CD47 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 145. Middle East and Africa Leukocyte Surface Antigen CD47 Market Size by Country (2021-2026) & (US$ Million) Table 146. Middle East and Africa Leukocyte Surface Antigen CD47 Market Share by Country (2021-2026) Table 147. Middle East and Africa Leukocyte Surface Antigen CD47 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 148. Middle East and Africa Leukocyte Surface Antigen CD47 Market Share Forecast by Country (2027-2032) Table 149. Key Raw Materials Table 150. Raw Materials Key Suppliers Table 151. Leukocyte Surface Antigen CD47 Distributors List Table 152. Leukocyte Surface Antigen CD47 Customers List Table 153. Research Programs/Design for This Report Table 154. Authors List of This Report Table 155. Secondary Sources Table 156. Primary Sources List of Figures Figure 1. Leukocyte Surface Antigen CD47 Image Figure 2. Global Leukocyte Surface Antigen CD47 Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Leukocyte Surface Antigen CD47 Market Size (2021-2032) & (US$ Million) Figure 4. Global Leukocyte Surface Antigen CD47 Sales (2021-2032) & (k units) Figure 5. PSTx-23 Image Figure 6. Global PSTx-23 Sales YoY Growth (2021-2032) & (k units) Figure 7. CC-90002 Image Figure 8. Global CC-90002 Sales YoY Growth (2021-2032) & (k units) Figure 9. B-6H12 Image Figure 10. Global B-6H12 Sales YoY Growth (2021-2032) & (k units) Figure 11. ALX-148 Image Figure 12. Global ALX-148 Sales YoY Growth (2021-2032) & (k units) Figure 13. Others Image Figure 14. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 15. Global Leukocyte Surface Antigen CD47 Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Leukocyte Surface Antigen CD47 Market Share by Type 2025 VS 2032 Figure 17. North America Leukocyte Surface Antigen CD47 Sales Market Share in Volume by Type in 2025 Figure 18. North America Leukocyte Surface Antigen CD47 Sales Market Share in Value by Type in 2025 Figure 19. Europe Leukocyte Surface Antigen CD47 Sales Market Share in Volume by Type in 2025 Figure 20. Europe Leukocyte Surface Antigen CD47 Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Leukocyte Surface Antigen CD47 Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Leukocyte Surface Antigen CD47 Sales Market Share in Value by Type in 2025 Figure 23. Latin America Leukocyte Surface Antigen CD47 Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Leukocyte Surface Antigen CD47 Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Leukocyte Surface Antigen CD47 Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Leukocyte Surface Antigen CD47 Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Leukocyte Surface Antigen CD47 Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Ischemia Reperfusion Injury Image Figure 30. Global Ischemia Reperfusion Injury Sales YoY Growth (2021-2032) & (k units) Figure 31. Kindney Transplant Rejection Image Figure 32. Global Kindney Transplant Rejection Sales YoY Growth (2021-2032) & (k units) Figure 33. Ovarian Cancer Image Figure 34. Global Ovarian Cancer Sales YoY Growth (2021-2032) & (k units) Figure 35. Lymphoma Image Figure 36. Global Lymphoma Sales YoY Growth (2021-2032) & (k units) Figure 37. Others Image Figure 38. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 39. Global Leukocyte Surface Antigen CD47 Market Size Overview by Application (2021-2032) & (US$ Million) Figure 40. Global Leukocyte Surface Antigen CD47 Market Share by Application 2025 VS 2032 Figure 41. North America Leukocyte Surface Antigen CD47 Sales Market Share in Volume by Application in 2025 Figure 42. North America Leukocyte Surface Antigen CD47 Sales Market Share in Value by Application in 2025 Figure 43. Europe Leukocyte Surface Antigen CD47 Sales Market Share in Volume by Application in 2025 Figure 44. Europe Leukocyte Surface Antigen CD47 Sales Market Share in Value by Application in 2025 Figure 45. Asia-Pacific Leukocyte Surface Antigen CD47 Sales Market Share in Volume by Application in 2025 Figure 46. Asia-Pacific Leukocyte Surface Antigen CD47 Sales Market Share in Value by Application in 2025 Figure 47. Latin America Leukocyte Surface Antigen CD47 Sales Market Share in Volume by Application in 2025 Figure 48. Latin America Leukocyte Surface Antigen CD47 Sales Market Share in Value by Application in 2025 Figure 49. Middle East and Africa Leukocyte Surface Antigen CD47 Sales Market Share in Volume by Application in 2025 Figure 50. Middle East and Africa Leukocyte Surface Antigen CD47 Sales Market Share in Value by Application in 2025 Figure 51. North America Leukocyte Surface Antigen CD47 Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. North America Leukocyte Surface Antigen CD47 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. North America Leukocyte Surface Antigen CD47 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. North America Leukocyte Surface Antigen CD47 Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Leukocyte Surface Antigen CD47 Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Europe Leukocyte Surface Antigen CD47 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Europe Leukocyte Surface Antigen CD47 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Europe Leukocyte Surface Antigen CD47 Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Leukocyte Surface Antigen CD47 Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 60. Asia-Pacific Leukocyte Surface Antigen CD47 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Leukocyte Surface Antigen CD47 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Asia-Pacific Leukocyte Surface Antigen CD47 Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Leukocyte Surface Antigen CD47 Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 64. Latin America Leukocyte Surface Antigen CD47 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Latin America Leukocyte Surface Antigen CD47 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Latin America Leukocyte Surface Antigen CD47 Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Leukocyte Surface Antigen CD47 Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 68. Middle East and Africa Leukocyte Surface Antigen CD47 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 69. Middle East and Africa Leukocyte Surface Antigen CD47 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 70. Middle East and Africa Leukocyte Surface Antigen CD47 Market Share by Country: 2021 VS 2025 VS 2032 Figure 71. Leukocyte Surface Antigen CD47 Value Chain Figure 72. Key Raw Materials Price Figure 73. Manufacturing Cost Structure Figure 74. Leukocyte Surface Antigen CD47 Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • PSTx-23
  • CC-90002
  • B-6H12
  • ALX-148
  • Others
Applications
  • Ischemia Reperfusion Injury
  • Kindney Transplant Rejection
  • Ovarian Cancer
  • Lymphoma
  • Others
Companies covered
  • Trillium Therapeutics Inc
  • Surface Oncology Inc
  • Forty Seven Inc
  • Celgene Corp
  • Aurigene Discovery Technologies Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Leukocyte Surface Antigen CD47 Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Leukocyte Surface Antigen CD47 Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Leukocyte Surface Antigen CD47 Market by Type
  6. 1.3.1 PSTx-23
  7. 1.3.2 CC-90002
  8. 1.3.3 B-6H12
  9. 1.3.4 ALX-148
  10. 1.3.5 Others
  11. 1.4 Global Leukocyte Surface Antigen CD47 Market Size by Type
  12. 1.4.1 Global Leukocyte Surface Antigen CD47 Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Leukocyte Surface Antigen CD47 Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Leukocyte Surface Antigen CD47 Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Leukocyte Surface Antigen CD47 Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Leukocyte Surface Antigen CD47 Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Leukocyte Surface Antigen CD47 Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Leukocyte Surface Antigen CD47 Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Leukocyte Surface Antigen CD47 Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Leukocyte Surface Antigen CD47 Industry Trends
  2. 2.2 Leukocyte Surface Antigen CD47 Industry Drivers
  3. 2.3 Leukocyte Surface Antigen CD47 Industry Opportunities and Challenges
  4. 2.4 Leukocyte Surface Antigen CD47 Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Leukocyte Surface Antigen CD47 Revenue (2021-2026)
  2. 3.2 Global Top Players by Leukocyte Surface Antigen CD47 Sales (2021-2026)
  3. 3.3 Global Top Players by Leukocyte Surface Antigen CD47 Price (2021-2026)
  4. 3.4 Global Leukocyte Surface Antigen CD47 Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Leukocyte Surface Antigen CD47 Major Company Production Sites & Headquarters
  6. 3.6 Global Leukocyte Surface Antigen CD47 Company, Product Type & Application
  7. 3.7 Global Leukocyte Surface Antigen CD47 Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Leukocyte Surface Antigen CD47 Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Leukocyte Surface Antigen CD47 Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Leukocyte Surface Antigen CD47 Tier 1, Tier 2, and Tier 3
4 Leukocyte Surface Antigen CD47 Regional Status and Outlook
  1. 4.1 Global Leukocyte Surface Antigen CD47 Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Leukocyte Surface Antigen CD47 Historic Market Size by Region
  3. 4.2.1 Global Leukocyte Surface Antigen CD47 Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Leukocyte Surface Antigen CD47 Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Leukocyte Surface Antigen CD47 Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Leukocyte Surface Antigen CD47 Forecasted Market Size by Region
  7. 4.3.1 Global Leukocyte Surface Antigen CD47 Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Leukocyte Surface Antigen CD47 Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Leukocyte Surface Antigen CD47 Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Leukocyte Surface Antigen CD47 by Application
  1. 5.1 Leukocyte Surface Antigen CD47 Market by Application
  2. 5.1.1 Ischemia Reperfusion Injury
  3. 5.1.2 Kindney Transplant Rejection
  4. 5.1.3 Ovarian Cancer
  5. 5.1.4 Lymphoma
  6. 5.1.5 Others
  7. 5.2 Global Leukocyte Surface Antigen CD47 Market Size by Application
  8. 5.2.1 Global Leukocyte Surface Antigen CD47 Market Size Overview by Application (2021-2032)
  9. 5.2.2 Global Leukocyte Surface Antigen CD47 Historic Market Size Review by Application (2021-2026)
  10. 5.2.3 Global Leukocyte Surface Antigen CD47 Forecasted Market Size by Application (2027-2032)
  11. 5.3 Key Regions Market Size by Application
  12. 5.3.1 North America Leukocyte Surface Antigen CD47 Sales Breakdown by Application (2021-2026)
  13. 5.3.2 Europe Leukocyte Surface Antigen CD47 Sales Breakdown by Application (2021-2026)
  14. 5.3.3 Asia-Pacific Leukocyte Surface Antigen CD47 Sales Breakdown by Application (2021-2026)
  15. 5.3.4 South America Leukocyte Surface Antigen CD47 Sales Breakdown by Application (2021-2026)
  16. 5.3.5 Middle East and Africa Leukocyte Surface Antigen CD47 Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Trillium Therapeutics Inc
  2. 6.1.1 Trillium Therapeutics Inc Company Information
  3. 6.1.2 Trillium Therapeutics Inc Business Overview
  4. 6.1.3 Trillium Therapeutics Inc Leukocyte Surface Antigen CD47 Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Trillium Therapeutics Inc Leukocyte Surface Antigen CD47 Product Portfolio
  6. 6.1.5 Trillium Therapeutics Inc Recent Developments
  7. 6.2 Surface Oncology Inc
  8. 6.2.1 Surface Oncology Inc Company Information
  9. 6.2.2 Surface Oncology Inc Business Overview
  10. 6.2.3 Surface Oncology Inc Leukocyte Surface Antigen CD47 Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Surface Oncology Inc Leukocyte Surface Antigen CD47 Product Portfolio
  12. 6.2.5 Surface Oncology Inc Recent Developments
  13. 6.3 Forty Seven Inc
  14. 6.3.1 Forty Seven Inc Company Information
  15. 6.3.2 Forty Seven Inc Business Overview
  16. 6.3.3 Forty Seven Inc Leukocyte Surface Antigen CD47 Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Forty Seven Inc Leukocyte Surface Antigen CD47 Product Portfolio
  18. 6.3.5 Forty Seven Inc Recent Developments
  19. 6.4 Celgene Corp
  20. 6.4.1 Celgene Corp Company Information
  21. 6.4.2 Celgene Corp Business Overview
  22. 6.4.3 Celgene Corp Leukocyte Surface Antigen CD47 Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Celgene Corp Leukocyte Surface Antigen CD47 Product Portfolio
  24. 6.4.5 Celgene Corp Recent Developments
  25. 6.5 Aurigene Discovery Technologies Ltd
  26. 6.5.1 Aurigene Discovery Technologies Ltd Company Information
  27. 6.5.2 Aurigene Discovery Technologies Ltd Business Overview
  28. 6.5.3 Aurigene Discovery Technologies Ltd Leukocyte Surface Antigen CD47 Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Aurigene Discovery Technologies Ltd Leukocyte Surface Antigen CD47 Product Portfolio
  30. 6.5.5 Aurigene Discovery Technologies Ltd Recent Developments
7 North America by Country
  1. 7.1 North America Leukocyte Surface Antigen CD47 Sales by Country
  2. 7.1.1 North America Leukocyte Surface Antigen CD47 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Leukocyte Surface Antigen CD47 Sales by Country (2021-2026)
  4. 7.1.3 North America Leukocyte Surface Antigen CD47 Sales Forecast by Country (2027-2032)
  5. 7.2 North America Leukocyte Surface Antigen CD47 Market Size by Country
  6. 7.2.1 North America Leukocyte Surface Antigen CD47 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Leukocyte Surface Antigen CD47 Market Size by Country (2021-2026)
  8. 7.2.3 North America Leukocyte Surface Antigen CD47 Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Leukocyte Surface Antigen CD47 Sales by Country
  2. 8.1.1 Europe Leukocyte Surface Antigen CD47 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Leukocyte Surface Antigen CD47 Sales by Country (2021-2026)
  4. 8.1.3 Europe Leukocyte Surface Antigen CD47 Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Leukocyte Surface Antigen CD47 Market Size by Country
  6. 8.2.1 Europe Leukocyte Surface Antigen CD47 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Leukocyte Surface Antigen CD47 Market Size by Country (2021-2026)
  8. 8.2.3 Europe Leukocyte Surface Antigen CD47 Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Leukocyte Surface Antigen CD47 Sales by Country
  2. 9.1.1 Asia-Pacific Leukocyte Surface Antigen CD47 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Leukocyte Surface Antigen CD47 Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Leukocyte Surface Antigen CD47 Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Leukocyte Surface Antigen CD47 Market Size by Country
  6. 9.2.1 Asia-Pacific Leukocyte Surface Antigen CD47 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Leukocyte Surface Antigen CD47 Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Leukocyte Surface Antigen CD47 Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Leukocyte Surface Antigen CD47 Sales by Country
  2. 10.1.1 South America Leukocyte Surface Antigen CD47 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Leukocyte Surface Antigen CD47 Sales by Country (2021-2026)
  4. 10.1.3 South America Leukocyte Surface Antigen CD47 Sales Forecast by Country (2027-2032)
  5. 10.2 South America Leukocyte Surface Antigen CD47 Market Size by Country
  6. 10.2.1 South America Leukocyte Surface Antigen CD47 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Leukocyte Surface Antigen CD47 Market Size by Country (2021-2026)
  8. 10.2.3 South America Leukocyte Surface Antigen CD47 Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Leukocyte Surface Antigen CD47 Sales by Country
  2. 11.1.1 Middle East and Africa Leukocyte Surface Antigen CD47 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Leukocyte Surface Antigen CD47 Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Leukocyte Surface Antigen CD47 Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Leukocyte Surface Antigen CD47 Market Size by Country
  6. 11.2.1 Middle East and Africa Leukocyte Surface Antigen CD47 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Leukocyte Surface Antigen CD47 Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Leukocyte Surface Antigen CD47 Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Leukocyte Surface Antigen CD47 Value Chain Analysis
  2. 12.1.1 Leukocyte Surface Antigen CD47 Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Leukocyte Surface Antigen CD47 Production Mode & Process
  7. 12.2 Leukocyte Surface Antigen CD47 Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Leukocyte Surface Antigen CD47 Distributors
  10. 12.2.3 Leukocyte Surface Antigen CD47 Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst